A STAT3-NFkB/DDIT3/CEBPβ axis modulates ALDH1A3 expression in chemoresistant cell subpopulations.
about
Head and Neck Squamous Cell Carcinoma Metabolism Draws on Glutaminolysis, and Stemness Is Specifically Regulated by Glutaminolysis via Aldehyde DehydrogenaseCurcumin blocks autophagy and activates apoptosis of malignant mesothelioma cell lines and increases the survival of mice intraperitoneally transplanted with a malignant mesothelioma cell line.Blockade of autophagy reduces pancreatic cancer stem cell activity and potentiates the tumoricidal effect of gemcitabine.HE4 promotes collateral resistance to cisplatin and paclitaxel in ovarian cancer cellsObesity enhances sepsis-induced liver inflammation and injury in miceButein inhibits cell proliferation and induces cell cycle arrest in acute lymphoblastic leukemia via FOXO3a/p27kip1 pathwayAutophagy Differentially Regulates Distinct Breast Cancer Stem-like Cells in Murine Models via EGFR/Stat3 and Tgfβ/Smad Signaling.Inhibition of the colony-stimulating-factor-1 receptor affects the resistance of lung cancer cells to cisplatinSTAT3/NF-κB-Regulated Lentiviral TK/GCV Suicide Gene Therapy for Cisplatin-Resistant Triple-Negative Breast Cancer.KCa3.1 channels and glioblastoma: in vitro studies.Endoglin Is Essential for the Maintenance of Self-Renewal and Chemoresistance in Renal Cancer Stem Cells.Citral reduces breast tumor growth by inhibiting the cancer stem cell marker ALDH1A3.The oncogenic Golgi phosphoprotein 3 like overexpression is associated with cisplatin resistance in ovarian carcinoma and activating the NF-κB signaling pathway.Leptin signaling and cancer chemoresistance: Perspectives.Transcription Factor C/EBP Homologous Protein in Health and Diseases.HSP90 inhibition alters the chemotherapy-driven rearrangement of the oncogenic secretome.ALDH1A3 affects colon cancer in vitro proliferation and invasion depending on CXCR4 status.The elevated activation of NFκB and AP-1 is correlated with differential regulation of Bcl-2 and associated with oral squamous cell carcinoma progression and resistance.3,4-Dihydroxyphenylacetic acid is a potential aldehyde dehydrogenase inducer in murine hepatoma Hepa1c1c7 cells.Constitutive Activation of STAT3 in Myeloma Cells Cultured in a Three-Dimensional, Reconstructed Bone Marrow Model.
P2860
Q33636562-C2838542-675A-4F14-93D8-6EA19012B3CDQ33798391-53ADC2C5-85E4-44C7-A57E-DF55345E5617Q36156256-E142B4A7-B24F-45C3-9DE7-F3546E5C688BQ36907257-0CACB757-2D6A-4867-B6FC-90A9CF3ECC37Q37047784-22C37071-757E-4F5F-9C98-6D3A4564B266Q37109845-38D829AE-B025-4982-A8D1-DD6CA0D94A02Q37187410-379458A0-A7AA-44EC-8C38-ACB2346FE7B2Q37636636-46C9447A-B590-4B68-98D1-E60BE8B26B5AQ37668555-8B7911FD-094E-42A8-BCD3-697A337DD09BQ38635288-E5ECCB96-69FB-425C-AB05-64DD8FBD6655Q41329894-D14A31C7-DEB6-4683-880D-6B1CE2CA4C89Q42025610-E01B8827-ACCA-4F38-A624-C144A084CAECQ42278865-C1FA0137-58B5-40F9-B792-03B840D03B19Q42365079-A34FE123-A751-493B-8A5F-7F2974C9E89BQ47304202-24C38F19-1C25-4305-87AB-68ADF43A6A06Q48292976-216E95B8-3543-423D-B63F-382E0B10C52EQ49860704-FA5A4392-6886-4682-A7F2-9239060B43E4Q51124740-A6EAD78E-EF02-469E-B024-5573974ECBA3Q51803435-F947D352-5F3A-4C41-AB64-35138D082D92Q55456143-9EE105AF-0FF9-4EE2-A81D-4834B288F905
P2860
A STAT3-NFkB/DDIT3/CEBPβ axis modulates ALDH1A3 expression in chemoresistant cell subpopulations.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
A STAT3-NFkB/DDIT3/CEBPβ axis ...... resistant cell subpopulations.
@ast
A STAT3-NFkB/DDIT3/CEBPβ axis ...... resistant cell subpopulations.
@en
type
label
A STAT3-NFkB/DDIT3/CEBPβ axis ...... resistant cell subpopulations.
@ast
A STAT3-NFkB/DDIT3/CEBPβ axis ...... resistant cell subpopulations.
@en
prefLabel
A STAT3-NFkB/DDIT3/CEBPβ axis ...... resistant cell subpopulations.
@ast
A STAT3-NFkB/DDIT3/CEBPβ axis ...... resistant cell subpopulations.
@en
P2093
P2860
P356
P1433
P1476
A STAT3-NFkB/DDIT3/CEBPβ axis ...... oresistant cell subpopulations
@en
P2093
Claudia Canino
Giovanni Blandino
Mario Cioce
Paola Marcato
YuYing Luo
P2860
P304
12637-12653
P356
10.18632/ONCOTARGET.3703
P407
P577
2015-05-01T00:00:00Z